Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1092 | 975 | 1157 | 1085 | 1266 | - |
Fund Return | 9.21% | -2.51% | 15.69% | 2.75% | 4.83% | - |
Place in category | 102 | 47 | 289 | 23 | 198 | - |
% in Category | 16 | 9 | 46 | 5 | 43 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS CH Institutional Fund 2 EquiP2X | 9.05B | 34.35 | 9.07 | 12.32 | ||
UBS CH Institutional Fund 2 EquiPAX | 4.44B | 28.57 | 7.61 | 9.70 | ||
UBS CH Vitainvest 50 World U | 4.37B | 8.31 | -0.67 | 2.51 | ||
UBS CH Institutional Fund 2 EquiSCX | 2.77B | 11.50 | -1.36 | 6.69 | ||
UBS CH Institutional Fund 2 EquiSCB | 2.77B | 11.45 | -1.42 | 6.63 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.46B | 9.01 | 1.94 | 5.88 | ||
Raiffeisen Futura Swiss Stock A | 2.12B | 7.81 | -1.29 | 5.90 | ||
UBS CH Equity Fund Swiss Income CHQ | 2.11B | 10.36 | 3.55 | 6.38 | ||
UBS CH Equity Fund Swiss Income CHF | 2.11B | 9.72 | 2.91 | 5.73 | ||
Pictet CH Institutional Swiss EquiI | 2B | 5.71 | -1.18 | 6.34 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 9.54 | 87.68 | +1.11% | |
Roche Holding Participation | CH0012032048 | 9.41 | 251.00 | +1.46% | |
Nestle | CH0038863350 | 9.05 | 74.08 | +0.14% | |
UBS Group | CH0244767585 | 8.20 | 27.07 | +1.35% | |
Zurich Insurance Group | CH0011075394 | 8.04 | 539.00 | +1.13% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Sell |
Technical Indicators | Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review